Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
10 p, 389.9 KB A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation / Nevens, Frederik (University Hospitals Leuven (Bèlgica)) ; Gustot, Thierry (C.U.B. Erasme Hospital) ; Laterre, Pierre-François (Cliniques Universitaires Saint-Luc) ; Lasser, Luc L. (CHU Brugmann) ; Haralampiev, Lyudmil E. (Multiprofile Hospital for Active Treatment (MEDICA), Ruse) ; Vargas, Victor (Hospital Universitari Vall d'Hebron) ; Lyubomirova, Desislava (University Multiprofile Hospital for Active Treatment "Georgi Stranski") ; Albillos, Agustín (Hospital Universitario Ramón y Cajal (Madrid)) ; Najimi, Mustapha (Institute of Experimental and Clinical Research, Brussels) ; Michel, Sébastien (Promethera Biosciences, Mont-Saint-Guibert) ; Stoykov, Ivaylo (Promethera Biosciences, Mont-Saint-Guibert) ; Gordillo, Noelia (Promethera Biosciences, Mont-Saint-Guibert) ; Vainilovich, Yelena (Promethera Biosciences, Mont-Saint-Guibert) ; Barthel, Virginie (Promethera Biosciences, Mont-Saint-Guibert) ; Clerget-Chossat, Nathalie (Promethera Biosciences, Mont-Saint-Guibert) ; Sokal, Etienne M. (Cliniques Universitaires Saint-Luc, UCLouvain, Pediatric Hepatology & Gastroenterology Unit) ; Universitat Autònoma de Barcelona
Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorate liver function in patients with acute-on-chronic liver failure (ACLF) or acute decompensation of cirrhosis (AD). [...]
2021 - 10.1016/j.jhepr.2021.100291
JHEP Reports, Vol. 3 (april 2021)  
2.
11 p, 2.3 MB First-in-human PeriCord cardiac bioimplant : scalability and GMP manufacturing of an allogeneic engineered tissue graft / Prat-Vidal, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rodríguez-Gómez, Luciano (Cell Therapy Service, Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà) ; Aylagas, Miriam (Hospital Universitari Vall d'Hebron) ; Nieto-Nicolau, Núria (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Gastelurrutia, Paloma (Institut d'Investigació Biomèdica de Bellvitge) ; Agustí, Elba (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Gálvez-Montón, Carolina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jorba, Ignasi (Institut de Bioenginyeria de Catalunya) ; Teis, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Monguió-Tortajada, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rudilla, F. (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Vives Armengol, Joaquim (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torrents-Zapata, Silvia (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Coca, María Isabel (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Reales, Laura (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Cámara, Maria-Luisa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cediel, Germán (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Farré, Ramon (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Coll-Bonet, Ruth (Research and Education. Banc de Sang i Teixits) ; Navajas, Daniel (Institut de Bioenginyeria de Catalunya) ; Vilarrodona, Anna (Banc de Sang i Teixits (Barcelona, Catalunya)) ; García López, Joan (Banc de Sang i Teixits (Barcelona, Catalunya)) ; Muñoz-Guijosa, Christian (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Querol, Sergi (Hospital Universitari Vall d'Hebron) ; Bayés-Genís, Antoni (Universitat Autònoma de Barcelona. Departament de Medicina) ; Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol ; Vall d'Hebron Institut de Recerca (VHIR) ; Universitat Autònoma de Barcelona. Departament de Medicina
Small cardiac tissue engineering constructs show promise for limiting post-infarct sequelae in animal models. This study sought to scale-up a 2-cm 2 preclinical construct into a human-size advanced therapy medicinal product (ATMP; PeriCord), and to test it in a first-in-human implantation. [...]
2020 - 10.1016/j.ebiom.2020.102729
EBioMedicine, Vol. 54 (april 2020)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.